Investigation of MDA-LDL (Malondialdehyde-Modified Low-Density Lipoprotein) as a Prognostic Marker for Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus

Clinica Chimica Acta - Netherlands
doi 10.1016/j.cca.2015.08.003
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Low Density Lipoprotein (LDL) in Type 2 Diabetes Mellitus

Medical Laboratory Analysis and Sciences Journal
2019English

Oxidized LDL and Malondialdehyde-Modified LDL in Patients With Acute Coronary Syndromes and Stable Coronary Artery Disease

Circulation
Cardiovascular MedicinePhysiologyCardiology
1998English

Oxidized Low Density Lipoprotein Is a Prognostic Marker of Transplant-Associated Coronary Artery Disease

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2000English

Screening for Asymptomatic Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus

Archives of endocrinology and metabolism
EndocrinologyMetabolismDiabetes
2016English

Lowering Low-Density Lipoprotein Cholesterol Levels in Patients With Type 2 Diabetes Mellitus

International Journal of General Medicine
Medicine
2014English

Relationship Between Coronary Artery Disease and Retinopathy in Patients With Type 2 Diabetes Mellitus

Internal Medicine
Internal MedicineMedicine
2013English

Type 2 Diabetes Mellitus Is Associated With Carotid Artery Plaques in Patients With Premature Coronary Heart Disease

Revista de Investigacion Clinica
Medicine
2018English

Role of Lipids in Type 2 Diabetes Mellitus for Causation of Coronary Artery Disease

International Journal of Clinical Biochemistry and Research
2018English

Multivessel Coronary Artery Disease in Diabetes Mellitus Patients

Kurdistan Journal of Applied Research
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy